Erythropoietin for the prevention of anaemia in neoplastic patients treated with cisplatin.
Department of Medical Oncology 1, Regina Elena Institute for Cancer Research, Rome, Italy.
T
T
Gamucci
M F
MF
Thorel
A M
AM
Frasca
D
D
Giannarell
F
F
Calabresi
D000328:Adult; D000368:Aged; D000740:Anemia / Q000139:chemically induced / Q000517:prevention & control*; D002945:Cisplatin / Q000009:adverse effects*; D004921:Erythropoietin / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D011994:Recombinant Proteins / Q000627:therapeutic use
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D002945:Cisplatin